Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary https://www.medrxiv.org/content/10.1101/2023.03.12.23287041
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary https://www.medrxiv.org/content/10.1101/2023.03.12.23287041